AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca enhertu (Daiichi Sankyo alliance) revenue ($M) ($M)
Form 6-K / Form 20-F Alliance Revenue Table
Latest, FY2025
1,798
Period ended Dec 31, 2025
Change on a year earlier
+25.1%
1,437 in FY2024
History
4 years
Since FY2021
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Enhertu (Daiichi Sankyo alliance) revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,798 | +25.1% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 1,437 | +40.6% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 1,022 | – | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 214 | – | Form 6-K FY2021Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Enhertu (Daiichi Sankyo alliance) revenue ($M) ($M), annual FY2021–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/alliance_enhertu
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.